These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 10280288)
1. Drug samples in the hospital revisited. Lipman AG Hosp Formul; 1987 Feb; 22(2):123. PubMed ID: 10280288 [No Abstract] [Full Text] [Related]
2. Minimizing the influence of drug marketing. Hester FG Hospitals; 1990 Aug; 64(15):80. PubMed ID: 2373503 [No Abstract] [Full Text] [Related]
3. How to crack the $2 billion hospital market for pharmaceuticals. Zellmer WA Med Mark Media; 1981 May; 16(5):16, 24. PubMed ID: 10251527 [No Abstract] [Full Text] [Related]
4. Pharmacy service: what are the goals of the pharmacy and therapeutics committee? Francke DE Hospitals; 1967 Oct; 41(20):99-100 passim. PubMed ID: 6065407 [No Abstract] [Full Text] [Related]
6. Mission, role, and functions of the P & T Committee. Bell JE; Evans PJ; Standish RC Hosp Formul; 1983 Jun; 18(6):639-40, 643-6. PubMed ID: 10260202 [TBL] [Abstract][Full Text] [Related]
7. [Safer drug handling in hospitals. A new task for the drug committee]. Osterman PO; Gyllenspetz L; Hartvig P; Levol R; Rane A; Söderström A Lakartidningen; 1996 Oct; 93(44):3917-20. PubMed ID: 8965581 [No Abstract] [Full Text] [Related]
8. When the pharmacy and therapeutics committee decides. Garrison TJ Hosp Pharm; 1979 Sep; 14(9):506-7. PubMed ID: 10243912 [No Abstract] [Full Text] [Related]
9. Drug diversion by hospitals. Provost GP Am J Hosp Pharm; 1968 Apr; 25(4):159. PubMed ID: 5655783 [No Abstract] [Full Text] [Related]
10. Appraising purposes and functions of the P. and T. committee. Katcher AL Hosp Top; 1969 Feb; 47(2):61-6. PubMed ID: 4975066 [No Abstract] [Full Text] [Related]
11. Drug detailing in the hospital: background for policy development. Chan J; Einarson T Can J Hosp Pharm; 1991 Jun; 44(3):161-6. PubMed ID: 10112744 [No Abstract] [Full Text] [Related]
12. Editorial: The ASHP council on clinical pharmacy and therapeutics. Zellmer WA Am J Hosp Pharm; 1974 Sep; 31(9):831. PubMed ID: 4423139 [No Abstract] [Full Text] [Related]
14. The other side of the fence: hospital P&T committee members' role in drug selection. Archambault GF Med Mark Media; 1978 May; 13(5):48, 50, 52 passim. PubMed ID: 10307029 [No Abstract] [Full Text] [Related]
15. Hospital pharmacists seek to control sales rep activities. Alt SJ Hosp Mater Manage; 1992 Apr; 17(4):2, 16. PubMed ID: 10170987 [No Abstract] [Full Text] [Related]
16. [Non-patient related drugs at homes for the aged]. Hunskår S; Sommersten AM Tidsskr Nor Laegeforen; 1988 Nov; 108(33):3086-8. PubMed ID: 3206496 [No Abstract] [Full Text] [Related]
17. Medicine's "gray market"': why alarm bells are ringing. Gest T; Lanier LK US News World Rep; 1985 Dec; 99(23):52. PubMed ID: 10274713 [No Abstract] [Full Text] [Related]
18. Reporting drug product defects--JCAHO. Hoffmann RP Hosp Pharm; 1989 Feb; 24(2):143-4. PubMed ID: 10318199 [No Abstract] [Full Text] [Related]
19. The acceptance of clinical pharmaceutical services. Lipman AG Hosp Formul; 1982 Jun; 17(6):783. PubMed ID: 10256039 [No Abstract] [Full Text] [Related]
20. An informed M.D can help control drug costs. Souhrada L Hospitals; 1989 Jun; 63(12):78. PubMed ID: 2731927 [No Abstract] [Full Text] [Related] [Next] [New Search]